Recruiting A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369 Conditions ALK Genomic Tumor Aberrations, Adenocarcinoma, Adenoma, +69 more Locations University of Colorado Cancer Center — Aurora, Colorado, United States Florida Cancer Specialists — Lake Mary, Florida, United States Dartmouth Hitchcock — Lebanon, New Hampshire, United States Brown University Health Cancer Institute — Providence, Rhode Island, United States View more locations Show fewer locations Loading locations... View Trial Details
